Moran Wealth Management LLC Has $4.11 Million Stake in Molina Healthcare, Inc $MOH

Moran Wealth Management LLC lowered its holdings in Molina Healthcare, Inc (NYSE:MOH) by 65.2% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 21,482 shares of the company’s stock after selling 40,195 shares during the quarter. Moran Wealth Management LLC’s holdings in Molina Healthcare were worth $4,111,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in the business. Baird Financial Group Inc. acquired a new position in Molina Healthcare during the 1st quarter worth about $210,000. NewEdge Advisors LLC raised its stake in shares of Molina Healthcare by 33.4% in the first quarter. NewEdge Advisors LLC now owns 1,106 shares of the company’s stock worth $364,000 after acquiring an additional 277 shares during the last quarter. Jones Financial Companies Lllp lifted its position in shares of Molina Healthcare by 713.3% during the first quarter. Jones Financial Companies Lllp now owns 1,651 shares of the company’s stock worth $544,000 after purchasing an additional 1,448 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Molina Healthcare by 19.4% during the first quarter. Goldman Sachs Group Inc. now owns 249,466 shares of the company’s stock valued at $82,172,000 after purchasing an additional 40,531 shares during the last quarter. Finally, Meiji Yasuda Asset Management Co Ltd. grew its stake in shares of Molina Healthcare by 18.5% during the first quarter. Meiji Yasuda Asset Management Co Ltd. now owns 1,031 shares of the company’s stock valued at $340,000 after purchasing an additional 161 shares during the last quarter. Institutional investors own 98.50% of the company’s stock.

Insider Activity at Molina Healthcare

In related news, Director Richard M. Schapiro sold 357 shares of the stock in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $143.02, for a total value of $51,058.14. Following the sale, the director directly owned 11,352 shares in the company, valued at $1,623,563.04. This trade represents a 3.05% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.10% of the stock is currently owned by company insiders.

Molina Healthcare Stock Up 4.1%

NYSE:MOH opened at $183.55 on Friday. The company has a quick ratio of 1.68, a current ratio of 1.68 and a debt-to-equity ratio of 0.92. Molina Healthcare, Inc has a 12-month low of $133.40 and a 12-month high of $359.97. The stock’s fifty day simple moving average is $156.21 and its 200-day simple moving average is $179.71. The firm has a market capitalization of $9.95 billion, a P/E ratio of 11.37 and a beta of 0.49.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, October 22nd. The company reported $1.84 EPS for the quarter, missing analysts’ consensus estimates of $3.97 by ($2.13). Molina Healthcare had a net margin of 1.98% and a return on equity of 22.95%. The company had revenue of $11.48 billion during the quarter, compared to the consensus estimate of $10.99 billion. During the same quarter in the prior year, the company posted $6.01 EPS. The company’s revenue for the quarter was up 11.0% compared to the same quarter last year. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. Equities research analysts expect that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on MOH. Weiss Ratings restated a “sell (d+)” rating on shares of Molina Healthcare in a research report on Wednesday, October 8th. Morgan Stanley set a $158.00 target price on Molina Healthcare in a research note on Friday, October 24th. Wells Fargo & Company boosted their target price on Molina Healthcare from $165.00 to $208.00 and gave the stock an “overweight” rating in a research report on Wednesday. Truist Financial set a $175.00 price target on Molina Healthcare in a report on Friday, October 24th. Finally, Wall Street Zen cut Molina Healthcare from a “hold” rating to a “sell” rating in a report on Saturday, October 25th. Three research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Molina Healthcare has a consensus rating of “Hold” and an average target price of $200.80.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.